Pictet–Spengler Reaction-Based Biosynthetic Machinery in Fungi

Wei Yan,Hui Ming Ge,Gang Wang,Nan Jiang,Ya Ning Mei,Rong Jiang,Sui Jun Li,Chao Jun Chen,Rui Hua Jiao,Qiang Xu,Seik Weng Ng,Ren Xiang Tan

DOI: https://doi.org/10.1073/pnas.1417304111

2014-01-01

Abstract:Significance The Pictet–Spengler (PS) reaction constructs many important phytochemicals such as morphine and camptothecin, but it has not yet been noticed in the fungal kingdom. Here, the startup of the PS reaction-based silent fungal biosynthetic machinery is presented to generate unforeseeably “unnatural” natural products of unprecedented carbon skeletons with antibacterial and acetylcholinesterase inhibitory activities. The gene-implied enzyme inhibition strategy is introduced to facilitate understandings of the key diversification steps. Collectively, the PS reaction-based fungal biosynthetic machinery that used to be silent has been set up to produce unpredictably novel molecules valuable for new biology and biomedicine. The Pictet–Spengler (PS) reaction constructs plant alkaloids such as morphine and camptothecin, but it has not yet been noticed in the fungal kingdom. Here, a silent fungal Pictet–Spenglerase (FPS) gene of Chaetomium globosum 1C51 residing in Epinephelus drummondhayi guts is described and ascertained to be activable by 1-methyl-l-tryptophan (1-MT). The activated FPS expression enables the PS reaction between 1-MT and flavipin (fungal aldehyde) to form “unnatural” natural products with unprecedented skeletons, of which chaetoglines B and F are potently antibacterial with the latter inhibiting acetylcholinesterase. A gene-implied enzyme inhibition (GIEI) strategy has been introduced to address the key steps for PS product diversifications. In aggregation, the work designs and validates an innovative approach that can activate the PS reaction-based fungal biosynthetic machinery to produce unpredictable compounds of unusual and novel structure valuable for new biology and biomedicine.